戻る Agenda
Digital Transformation
Session Chair(s)
Max Wegner, PHARMD, RPH
Head Regulatory Affairs
Bayer AG, Germany
Artificial Intelligence (AI) will transform healthcare product development with enormous potential to benefit patients, but also other stakeholders including regulators and industry. From data-driven diagnosis to the development of previously-unimagined treatment models, AI is radically shaping healthcare's future. This session will be chaired by Dr. Max Wegner, Head Regulatory Affairs at Bayer, and focus on Digital Transformation and AI Use Cases. The session will examine the transforming digital world around us, particularly from a regulatory affairs perspective, featuring experts who will provide both industry and regulators perspectives.
Learning Objective : Participants will be introduced to the digital trends in Regulatory Affairs Participants will be able to point out the most relevant digital technologies in Regulatory Affairs Participants will hear about potential challenges in applying digital technologies to Regulatory Affairs
Speaker(s)
Digital Transformation and AI Use Cases
Regina Freunscht
Merck Healthcare KGaA, Germany
VP, Global Head of Regulatory Affairs Operations
The Digital Future of Regulatory Affairs – Data, Robotics and Artificial intelligence
Niels Leander, PHD
Eraneos, Denmark
Partner - Life Sciences
Panelist
Nikolai Constantin Brun, MD
Danish Medicines Agency, Denmark
Co-Chair, EMA-MHA Big Data Task Force; Dir, Div for Medical Eval & Biostatistics